• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2022 Feb 24;28(4).
doi: 10.3201/eid2804.212037. Online ahead of print.
Durability of Antibody Response and Frequency of SARS-CoV-2 Infection 6 Months after COVID-19 Vaccination in Healthcare Workers

Eric D Laing, Carol D Weiss, Emily C Samuels, Si'Ana A Coggins, Wei Wang, Richard Wang, Russell Vassell, Spencer L Sterling, Marana S Tso, Tonia Conner, Emilie Goguet, Matthew Moser, Belinda M Jackson-Thompson, Luca Illinik, Julian Davies, Orlando Ortega, Edward Parmelee, Monique Hollis-Perry, Santina E Maiolatesi, Gregory Wang, Kathleen F Ramsey, Anatalio E Reyes, Yolanda Alcorta, Mimi A Wong, Alyssa R Lindrose, Christopher A Duplessis, David R Tribble, Allison M W Malloy, Timothy H Burgess, Simon D Pollett, Cara H Olsen, Christopher C Broder, Edward Mitre

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies decay but persist 6 months postvaccination; lower levels of neutralizing titers persist against Delta than wild-type virus. Of 227 vaccinated healthcare workers tested, only 2 experienced outpatient symptomatic breakthrough infections, despite 59/227 exhibiting serologic evidence of SARS-CoV-2 infection, defined as presence of nucleocapsid protein antibodies.

Keywords: BNT162b2; COVID-19; SARS-CoV-2; United States; coronavirus disease; healthcare workers; respiratory infections; severe acute respiratory syndrome coronavirus 2; vaccine-preventable diseases; viruses; zoonoses.
 
Back
Top Bottom